Cbfβ-deficient mice also demonstrated preserved LV contractile function thus confirming (alongside our four other approaches to inhibit RUNX1 within the heart) that inhibiting RUNX1 within cardiomyocytes is a therapeutically tractable approach with translational potential to preserve cardiac contractile function following MI. This evidence concerns the gene RUNX1 and myocardial infarction.